News

May 2, 2017

Therapeutic Potential of Soybean Proteins for IBD Symptoms Seen in Mice

News

Results from a preclinical study at Penn State show that soybean proteins can reduce inflammation and protect the gut barrier in mouse models of inflammatory bowel disease (IBD). These results ... Read more

April 28, 2017

Immune Therapy Shows Response and Remission in Crohn’s Patients, Study Finds

News

Patients with Crohn’s disease benefit from treatment with a new platform of immunotherapies designed to restore the body’s innate immune system, a study has found. The announcement was made by ... Read more

April 27, 2017April 27, 2017

Crohn’s & Colitis Foundation Introduces 7 New National Trustees

News

The Crohn’s & Colitis Foundation is welcoming seven new members of its National Board of Trustees to oversee the management of the organization’s policies, practices, principles, affairs, funds and property. “We ... Read more

April 26, 2017April 26, 2017

Mutations in INAVA Gene May Increase Risk of IBD, Yale Study Shows

News

Mutations of the INAVA gene may boost the risk of inflammatory bowel disease (IBD), according to a new study whose findings not only explain the pathological mechanisms underlying IBD, but may also help design new ... Read more

April 25, 2017April 25, 2017

Renflexis, Biosimilar for Remicade to Treat Crohn’s and UC, Approved by FDA

News

Renflexis (infliximab-abda), a biosimilar of Remicade (infliximab), has been approved in the U.S. to treat a number of autoimmune diseases, including adult and pediatric Crohn’s disease and adult ulcerative colitis. Samsung Bioepis, which ... Read more

April 24, 2017

Cannabinoid Combo Therapy Ended Teen’s Bowel Disease Symptoms, Study Reports

News

A 13-year-old boy whose Crohn’s disease and colitis had failed to respond to standard treatments became symptom-free with a combo therapy that included cannabinoids, the cannabinoid therapy maker Vitality Biopharma reported. The study ... Read more

April 21, 2017

RedHill Wins Two More U.S. Patents on Gastrointestinal Therapy BEKINDA

News

RedHill Biopharma has received two more U.S. patents for its gastrointestinal therapy BEKINDA (ondansetron). The patents cover RedHill’s propriety formulation of its extended-release ondansetron tablet, and the way BEKINDA is ... Read more

April 20, 2017

Hospitalization Rates in Crohn’s Disease Suggest Patient Education Efforts Are Needed

News

Estimated hospitalization rates for Crohn’s disease have increased in the U.S., despite the introduction of treatments that researchers expected would improve remission and reduce hospitalizations. This led researchers to conclude that ... Read more

April 19, 2017

Immuron Announces Positive Results of IMM-124E in Acute Colitis Research Program

News

Australia’s Immuron announced beneficial results of IMM-124E in acute models of colitis, including clinical parameters, tissue analysis, and immunological biomarkers. Colitis refers mainly to ulcerative colitis and Crohn’s disease, major categories ... Read more

April 18, 2017April 18, 2017

Pfizer Awards Grant to UC Riverside Researchers for Discovery of IBD Therapeutic Target

News

Pfizer has awarded $150,000 to Declan McCole, PhD, and his team to find a therapeutic target for correcting intestinal barrier defects for patients with inflammatory bowel disease (IBD) who have mutations in the ... Read more